SCHEMBL7843894

SCHEMBL7843894

CCc1ccc(-c2cc(OC)ccn2)cc1N(C(=N)NC(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.34
CTSB P07858 1/20 0.34
PDPK1 O15530 1/20 0.34
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
AAK1 Q2M2I8 10/20 0.33
ACACB O00763 1/20 0.33
ACACA Q13085 1/20 0.33
DYRK1A Q13627 2/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
SYK P43405 1/20 0.32
SREBF2 Q12772 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7847267 0.84 ACACB (0.36) CCR1CCR5CCR8AAK1ACACB
SCHEMBL7240471 0.78 CCR1 (0.34) CCR1CCR5CCR8AAK1DYRK1A
SCHEMBL7846735 0.72 CNR1 (0.40) AAK1ACACBACACA
SCHEMBL7843889 0.72 PLAU (0.37) CCR1CCR5CCR8USP2ALDH1A1
SCHEMBL7843891 0.72 PLAU (0.37) CCR1CCR5CCR8USP2ALDH1A1
SCHEMBL7230744 0.70 AAK1 (0.40) CCR1CCR5CCR8AAK1ACACB
SCHEMBL29597741 0.70 CTSL (0.38) CTSLCTSBALDH1A1CYP1A2
SCHEMBL7239061 0.69 AAK1 (0.41) CCR1CCR5CCR8AAK1
SCHEMBL7232327 0.69 CCR1 (0.38) CCR1CCR5CCR8AAK1
SCHEMBL7229573 0.69 CCR1 (0.40) CCR1CCR5CCR8AAK1ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed